Skip to main content
Sirio Pharma Co., Ltd. logo

Sirio Pharma Co., Ltd. — Investor Relations & Filings

Ticker · 300791 ISIN · CNE100003NB0 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,177 across all filing types
Latest filing 2025-09-15 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300791

About Sirio Pharma Co., Ltd.

https://www.siriopharma.com

Sirio Pharma Co., Ltd. is a global contract development and manufacturing organization (CDMO) specializing in dietary supplements and nutraceuticals. The company provides comprehensive services encompassing product formulation, manufacturing, and packaging. Its portfolio includes diverse delivery formats such as softgels, gummies, tablets, hard capsules, powders, and oral liquids. Sirio Pharma emphasizes innovation in delivery systems, offering specialized solutions like plant-based softgels and advanced probiotic formulations. The organization adheres to rigorous quality management systems and maintains multiple international certifications to meet global regulatory standards. Serving an international clientele, the company supports health and wellness brands through scalable production capacities and integrated supply chain solutions.

Recent filings

Filing Released Lang Actions
关于参加广东辖区2025年投资者网上集体接待日活动的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (518 characters) about the company's participation in an investor online collective reception day organized by regulatory and industry bodies. It mentions interaction with investors regarding the 2025 half-year performance and company governance but does not contain any actual financial statements or detailed financial data. It is an announcement of an event related to investor relations rather than a financial report or detailed presentation. The document is not a report itself but a notice about an upcoming investor interaction event. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2025-09-15 Chinese
关于高级管理人员增持公司股份的公告
Director's Dealing Classification · 100% confidence The document is an announcement regarding a senior management personnel (the company's Vice General Manager and Acting Financial Officer) increasing their shareholding in the company. It details the number of shares purchased, the price, the date, and compliance with relevant securities laws. There is no financial report, earnings data, or regulatory certification. The content fits the definition of a Director's Dealing report, which covers personal share transactions by company directors and executives (insider trades). The document length is short and focused solely on this insider share purchase disclosure, confirming it is not a full financial report or other category.
2025-09-09 Chinese
关于完成工商变更登记并取得换发营业执照的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the completion of a business registration change and the issuance of a new business license following a change in registered capital. It includes details about the new registered capital, company information, and legal representative. There is no financial data, no detailed report, no meeting materials, or voting results. The document is a regulatory announcement about corporate registration changes, which fits best under Regulatory Filings (RNS) as it does not match other specific categories like capital changes (SHA) which usually involve share issuance or stock splits, not registration changes.
2025-09-04 Chinese
2025年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "2025 年半年度报告全文" which translates to "2025 Semi-Annual Report Full Text." It includes detailed sections such as company overview, financial data, management discussion and analysis, risk factors, governance, and a full set of financial statements including audit reports. The document covers the reporting period from January 1, 2025 to June 30, 2025, which is a period shorter than a full fiscal year, consistent with an interim or quarterly report. The length of the document (15,000 characters) and the presence of substantive financial data and analysis confirm it is a comprehensive financial report for a half-year period. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2025
2025-08-25 Chinese
2025年半年度报告摘要
Interim / Quarterly Report Classification · 100% confidence The document is titled as "2025 年半年度报告摘要" which translates to "2025 Semi-Annual Report Summary." It contains detailed financial data such as revenue, net profit, earnings per share, asset and liability ratios, and other financial indicators for the half-year period. It also includes information about shareholders, stock pledges, bond details, management changes, and other corporate activities relevant to the half-year period. The length of the document (6780 characters) and the presence of substantive financial data and analysis confirm it is a financial report rather than a mere announcement. The document is a comprehensive interim report covering the company's financial performance and business activities for the first half of 2025. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2025
2025-08-25 Chinese
2025半年度非经营性资金占用及其他关联资金往来情况汇总表
Regulatory Filings Classification · 90% confidence The document is a detailed tabular summary of non-operating fund occupation and other related party fund transactions for the half-year period of 2025. It includes specific financial figures related to intercompany loans and receivables among subsidiaries and related parties. The document is relatively short (1747 characters) and contains substantive financial data, but it is not a full financial report like an interim or annual report. It appears to be a specific financial summary related to related party transactions, which is typically part of audit or regulatory disclosures but not a standalone audit report or annual report. It is not an announcement or a certification but a financial summary table. Given the nature and content, it best fits under Regulatory Filings (RNS) as a miscellaneous regulatory disclosure that does not fit other categories like Annual Report, Interim Report, or Audit Report. Confidence is high due to clear financial data and the document's nature.
2025-08-25 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.